OHAND · WA40404
Public neurological clinical research study information. Check the current recruitment status in the live Wix study record.
A Phase IIIb multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of ocrelizumab in adults with primary progressive multiple sclerosis. EudraCT: 2018-001511-73
Sponsor: ROCHE
Phase: III
Area: Neuroimmunology